Determination of Hydrochlorothiazide in Human Plasma by HPLC and Applicability to Oral Bioavailability in Korean Healthy Male Volunteers

HPLC를 이용한 혈중 히드로클로로티아지드의 분석 및 이를 이용한 한국인 성인남성에 대한 생체이용률 평가

  • Published : 2006.10.01

Abstract

A simple and sensitive high-performance liquid chromatographic method for quantitation of hydrochlorothiazide in human plasma was developed and bioavailability parameters of hydrochlorothiazide were assessed in Korean healthy male volunteers. Caffeine was used as an internal standard. Hydrochlorothiazide and internal standard in plasma sample were extracted using tert-butylmethylether (TBME). A centrifuged upper layer was then evaporated and reconstituted with mobile phase of acetonitrile-25 mM phosphate buffer (20/80, pH 2.5). The reconstituted samples were injected into a Luna C18 column $(250{\times}4.6\;mm,\;5{\mu}m)$ at a flow-rate of 1.0 ml/min. The wavelength was set at 230 nm and no endogenous substances were found to interfere, A linear relationship for hydrochlorothiazide was found in the range of $10{\sim}300\;ng/ml$. The lower limit of quantitation (LLOQ) was 10 ng/ml with acceptable precision and accuracy. Assayed in plasma, the intra- and inter-day validation for all coefficients of variation (R.S.D.%) were found less than 15%. Main pharmacokinetic parameters of 50mg of hydrochlorothiazide were revealed as follows: $AUC_t\;1761{\pm}509.0\;ng{\cdot} hr\;ml,\;C_{max}\;296.5{\pm}95.5\;ng/ml,\;T_{max}\;1.94{\pm}0.85hr,\;K_{el}\;0.12{\pm}0.04\;hr^{-1}\;and T_{12}\;6.81{\pm}2.92\;hr.\;C_{max}\;and\;T_{max}$ were in accordance with the values $(270{\sim}350\;ng/ml\;and\;1.9{\sim}2.7\;hr)$ of Caucasian.

Keywords

References

  1. Beermann, B., Groschinsky-Grind, M. and Rosen, A. : Absorption, metabolism and excreation of hydrochlorothiazide. Clin. Pharmacol. Ther. 19, 531 (1976) https://doi.org/10.1002/cpt1976195part1531
  2. Beermann, B. and Groschinsky-Grind, M. : Pharmacokinetics of hydrochlorothiazide in man. Eur. J. Clin. Pharmacol. 12, 297 (1977) https://doi.org/10.1007/BF00607430
  3. Niemeyer, C., HasenfuB, G., Wais, U., Knauf, H., Schafer- Korting, M. and Mutschler, E. : Pharmacokinetics of hydrochlorothiazide inrelation to renal function. Eur. J. Clin. Pharmacol. 24, 661 (1983) https://doi.org/10.1007/BF00542218
  4. Bank, N., Lief, P. D. and Piczon, O. : Use of diuretics in treatment of hypertension secondary to renal disease. Arch. Intern. Med. 138, 1524 (1978) https://doi.org/10.1001/archinte.138.10.1524
  5. Wollam, G. L., Tarazi, R. C., Bravo, E. L. and Dustan, H. P. : Diuretic potency of combined hydrochlorothiazide and furosemide therapy in patients with azotemia. Am. J. Med. 72, 929 (1982) https://doi.org/10.1016/0002-9343(82)90854-3
  6. Bennett, W. M., McDonald, W. J., Kuehnel, E., Hartnett, M. N. and Porter, G. A. : Do diuretics have antihypertensive properties independent of natriuresis- Clin. Pharmacol. Ther. 22, 499 (1977) https://doi.org/10.1002/cpt1977225part1499
  7. Ndindayino, F., Vervaet, C., Mooter, G. Van den and Remon, J. P. : Bioavailability of hydrochlorothiazide from isomalt-based moulded tablets. International Journal of Pharmaceutics 246, 199 (2002) https://doi.org/10.1016/S0378-5173(02)00354-X
  8. Vervaet, C. and Remon, J. P. : Bioavailability of hydrochlorothiazide from pellets, made by extrusion/spheronisation, containing polyethylene glycol 400 as a dissolution enhancer. Pharmaceutical Research 14, 1644 (1997) https://doi.org/10.1023/A:1012151006742
  9. Corveleyn, S. and Remon, J. P. : Bioavailability of hydrochlorothiazide : conventional versus freeze-dried tablets. International Journal of Pharmaceutics 173, 149 (1998) https://doi.org/10.1016/S0378-5173(98)00216-6
  10. 식품의약품안전청 고시 제2002-60호(2002. 11. 22) : 생물학적동 등성시험기준
  11. 식품의약품안전청 고시 제1999-67호(2000. 1. 4) : 의약품임상시험 관리기준
  12. Blume, C. D., Williams, R. L., Upton, R. A., Lin, E. T. and Benet, L. Z. : Bioequivalence study of a new tablet formulation of triamterene and hydrochlorothiazide. Am. J. Med. 77, 59 (1984) https://doi.org/10.1016/S0002-9343(84)80009-1
  13. Herman, J., Remon, J. P., Lefebvre, R., Bogaert, M., Klinger, G. H. and Schwartz, J. B. : The dissolution rate and bioavailability of hydrochlorothiazide in pellet formulations. J. Pharm. Pharmacol. 40, 157 (1988) https://doi.org/10.1111/j.2042-7158.1988.tb05209.x